Universal Ibogaine Inc. (IBOGF)
OTCMKTS · Delayed Price · Currency is USD
0.0120
+0.0055 (84.62%)
Feb 12, 2026, 1:43 PM EST
Universal Ibogaine Market Cap
Universal Ibogaine has a market cap or net worth of $1.14 million as of February 12, 2026. Its market cap has decreased by -49.25% in one year.
Market Cap
1.14M
Enterprise Value
2.93M
Revenue
1.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since October 5, 2021, Universal Ibogaine's market cap has decreased from 27.27M to 1.14M, a decrease of -95.81%. That is a compound annual growth rate of -51.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 1.14M | 0.23% |
| Dec 31, 2025 | 1.14M | 6.38% |
| Dec 31, 2024 | 1.07M | 47.59% |
| Dec 28, 2023 | 726.62K | -65.76% |
| Dec 30, 2022 | 2.12M | -88.73% |
| Dec 31, 2021 | 18.82M | -30.97% |
| Oct 5, 2021 | 27.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Exousia Pro | 1.54M |
| inTerra Resources | 1.49M |
| International Stem Cell | 1.32M |
| Sigyn Therapeutics | 1.20M |
| CERo Therapeutics Holdings | 1.19M |
| Halberd | 1.18M |
| Evofem Biosciences | 1.15M |
| Emmaus Life Sciences | 1.08M |